Outcome of differentiated thyroid cancer in Graves' patients

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 8, 1998, Pages 2805-2809

  Pellegriti, Gabriella ^a   Belfiore, Antonino ^a,c   Giuffrida, Dario ^a   Lupo, Lorenzo ^b   Vigneri, Riccardo ^a  

^a GARIBALDI HOSPITAL   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c Ist Med Int Malat Endocr M   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE;

ADULT; ARTICLE; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GRAVES DISEASE; HUMAN; MALE; METASTASIS; PRIORITY JOURNAL; RISK ASSESSMENT; THYROID CANCER; TREATMENT PLANNING; TUMOR DIFFERENTIATION;

ADULT; AGED; FEMALE; GRAVES DISEASE; HUMANS; IMMUNOGLOBULINS, THYROID-STIMULATING; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; THYROID NEOPLASMS;

EID: 0031752926     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.8.2805     Document Type: Article

References (33)

1. Belfiore A, Garofalo MR, Giuffrida D, et al. 1990 Increased aggressiveness of thyroid cancer in patients with Graves' disease. J Clin Endocrinol Metab. 70:830-835.
2. Filetti S, Belfiore A, Amir SM, et al. 1988 The role of thyroid-stimulating antibodies of Graves' disease in differentiated thyroid cancer. N Engl J Med. 318:753-759.
3. Belfiore A, Pellegriti G, Milone G, et al. 1995 Early occurrence of a thyroid carcinoma in a patients who developed Graves' disease after treatment for Hodgkin disease. J Endocrinol Invest. 18:869-871.
4. La Rosa GL, Belfiore A, Giuffrida D, et al. 1991 Evaluation of the fine needle aspiration biopsy in the preoperative selection of cold thyroid nodules. Cancer. 67:2137-2141.
5. Rapaport B, Filetti S, Takai N, Seto P, Halverson G. 1982 Studies on the cyclic AMP response to the thyroid stimulating immunoglobulin (TSI) and thyrotropin (TSH) in human thyroid cell monolayers. Metabolism. 31:1159-1167.
6. Heidinger CHR, Williams ED, Sobin LH. 1988. World Health Organization histological typing of thyroid tumors, 2nd ed. Berlin: Springer-Verlag; 9-11.
7. Beahrs OH, Henson DE, Hutter RVP, Myers M, eds. 1988 American Joint Commission on Cancer: manual for staging of cancer, 3rd ed. Philadelphia: Lippincott. pp 55-60.
8. Belfiore A, Gangemi P, Costantino A, et al. 1997 Negative/low expression of the MET/hepatocyte growth factor receptor identifies papillary thyroid carcinomas with high risk of distant metastases. J Clin Endocrinol Metab. 82:2322-2328.
9. Cox DR. 1972 Regression models and life-tables. J R Stat Soc B. 34:187-202.
10. Ain KB. 1995 Papillary thyroid carcinoma - etiology, assessment and therapy. Endocrinol Metab Clin North Am. 24:711-760.
11. Sokal JE. 1954 Incidence of malignancy in toxic and nontoxic nodular goiter. JAMA. 154:1321-1325.
12. Farbota LM, Clandra DB, Lawrence AM, Paloyan R. 1985 Thyroid carcinoma in Graves' disease. Surgery. 98:1148-52.
13. Behar R, Arganini M, Wu TC, McCormick M, Strauss FH, De Groot LJ. 1986 Graves' disease and thyroid cancer. Surgery. 100:1121-1127.
14. Pacini F, Elisei R, Di Coscio GC, et al. 1988 Thyroid carcinoma in thyrotoxic patients treated by surgery. J Endocrinol Invest. 11:107-112.
15. Hales IB, McElduff, Crummer P, et al. 1992 Does Graves' disease or thyrotoxicosis affect the prognosis of thyroid cancer. J Clin Endocrinol Metab. 75:886-889.
16. Ozaki O, Ito K, Kobayashi K, Toshima K, Iwasaki H, Yashiro T. 1990 Thyroid carcinoma in Graves' disease. World J Surg. 14:437-444.
17. Edmonds CJ, Tellez M. 1988 Hyperthyroidism and thyroid cancer. Clin Endocrinol (Oxf). 28:253-259.
18. Yeo PP, Wang KW, Sinniah R, et al. 1982 Thyrotoxicosis and thyroid cancer. Aust N Z J Med. 12:598-593.
19. Mazzaferri EL. 1990 Thyroid cancer and Graves' disease. J Clin Endocrinol Metab. 70:826-829.
20. Farid NR, Shi Y, Zou M. 1994 Molecular basis of thyroid cancer. Endocr Rev. 15:202-232.
21. Fagin JA. 1994 Molecular pathogenesis of human thyroid neoplasms. Thyroid Today. 17:1-7.
22. Katz SB, Garcia AJ, Niepomniszcze H. 1997 Development of Graves' Disease nine years after total thyroidectomy due to follicular carcinoma of the thyroid. Thyroid. 7:909-911.
23. Vansande J, Leieune C, Ludgate M, et al. 1992 Thyroid stimulating immunoglobulins, like thyrotropin activate both the cyclic AMP and the PIP2 cascades in CHO cells expressing the TSH receptor. Mol Cell Endocrinol. 88:1-3.
24. Huber GK, Safirstein R, Neufeld D, Davies TF. 1991 Thyrotropin receptor autoantibodies induce human thyroid cell growth and c-fos activation. J Clin Endocrinol Metab. 72:1142-1147.
25. Kashima K, Yokoyama S, Daa T, Takahashi K, Nakayama I, Noguchi S. 1996 c-myc expression is associated with increased proliferation activity in thyroid follicular cells of Graves' disease as stimulated by autoantibodies. Eur J Endocrinol. 135:69-76.
26. Sato K, Yamazaki K, Shizume K, et al. 1995 Stimulation by thyroid-stimulating hormone and Graves' immunoglobulin G of vascular endothelial growth factor mRNA expression in human thyroid follicles in vitro and flt mRNA expression in the rat thyroid in vivo. J Clin Invest. 96:1295-1302.
27. Viglietto G, Romano A, Manzo G, et al. 1997 Upregulation of the angiogenic factors PIGF, VEGF and their receptors (Flt-1, Flk-1/KDR) by TSH in cultured thyrocytes and in the thyroid gland of thiouracil-fed rats suggest a TSH-dependent paracrine mechanism for goiter hypervascularization. Oncogene. 15:2687-2698.
28. Russo D, Tumino S, Arturi F, et al. 1997 Detection of an activating mutation of the thyrotropin receptor in a case of an autonomously hyperfunctioning thyroid insular carcinoma. J Clin Endocrinol Metab. 82:735-738.
29. Di Cerbo A, Di Paola R, Bonati M, Zingrillo M, De Filippis V, Corda D. 1995 Subgroups of Graves' patients identified on the basis of the biochemical activities of their immunoglobulins. J Clin Endocrinol Metab. 80:2785-2790.
30. Juhasz F, Boros P, Szegedi G, et al. 1989 Immunogenetic and immunologic studies of differentiated thyroid cancer. Cancer. 63:1318-1326.
31. Fiumara A, Belfiore A, Russo G, et al. 1997 In situ evidence of neoplastic phagocytosis by macrophages in papillary thyroid cancer. J Clin Endocrinol Metab. 82:1615-1620.
32. Boyd CK, Baker JR. 1996 The immunology of thyroid cancer. Endocrinol Metab Clin North Am. 25:159-179.
33. Mazzaferri EL, Jhiang SM. 1994 Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med. 97: 418-428.